Multibillion-dollar contracts give drug makers liability shields, patent ownership and leeway on delivery dates and pricing — and promises that much of it will not be made public.
Author: Matt Apuzzo and Selam Gebrekidan
For Covid-19 Vaccines, Some Are Too Rich — and Too Poor
Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.
Trapped at Sea by Covid-19 Lockdowns, Crew Members Plead for Help
The seafarers who deliver gas, food and medicine are being forced to keep working. They cannot leave the ship: ‘We want to go home.’
Can’t Get Tested for Covid-19? Maybe You’re in the Wrong Country
Decisions and blunders made months ago have caused testing disparities worldwide. The science, it turns out, was the easy part.
Can’t Get Tested? Maybe You’re in the Wrong Country
Decisions and blunders made months ago have caused testing disparities worldwide. The science, it turns out, was the easy part.
Who Keeps Europe’s Farm Billions Flowing? Often, Those Who Benefit
Conflict-of-interest rules are uneven. Influence-peddling is murky. The enormous E.U. subsidy program is built to keep the money moving.